2021
DOI: 10.1055/s-0041-1730192
|View full text |Cite
|
Sign up to set email alerts
|

Budget Impact des Oncotype DX® Tests im Vergleich zu anderen Genexpressionstests bei Patientinnen mit einem Mammakarzinom im Frühstadium in Deutschland

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles